STELARA^® (ustekinumab) Has Expanded 
First-Line Biologic^* Access for Your Patients¹

Supports eligible, commercially insured patients until they receive coverage for their prescribed treatment

Janssen Link enables eligible patients to receive subcutaneous STELARA^®  at no cost until they receive coverage or until the end of the current program year if the following program requirements are met.

Janssen Link Program Requirements

• Patient has been prescribed subcutaneous STELARA^® for an on-label, FDA-approved indication
• Patient has commercial insurance that has delayed (>5 business days) or denied their treatment
• Patient does not use any state or federal government-funded healthcare program to cover a portion of medication costs, such as Medicare, Medicaid, TRICARE, Department of Defense, or Veterans Administration
• Patient cannot submit the value of the free product as a claim for payment to any third-party payer
• Patient is not eligible if the prior authorization is denied due to missing information on coverage determination form, use for a non-FDA-approved indication, or invalid clinical rationale
• Patient must contact Janssen CarePath if the patient switches from commercial health insurance coverage to a government-funded healthcare program at any point during the program year
• Prescriber must complete and submit an electronic enrollment in the Provider Portal or fax the Benefits Investigation and Prescription Form to Janssen CarePath to enroll patient in Janssen Link
  • Janssen CarePath cannot accept any information without an executed Business Associate Agreement or Patient Authorization on file. The patient authorization can be found on the Benefits Investigation and Prescription Form. Or patient can create an account on MyJanssenCarePath.com and electronically sign a patient authorization there
• Prescriber agrees to not purchase the Janssen medication on behalf of Janssen Link patient participants, and not bill commercial payers for any part of the prescribed subcutaneous treatment
• Prescriber completes and submits a form of coverage determination (ie, prior authorization or prior authorization with exception) to the commercial insurance
• If coverage is denied, prescriber challenges the coverage denial with an exception, Letter of Medical Necessity, or appeal

How Janssen Link Works

• Program covers the cost of therapy only – not associated administration cost
• No portion of the value of the free product will count towards the patient’s applicable out-of-pocket cost-sharing obligations
• Program year runs March 1 – February 28
• Janssen CarePath reserves the right to cancel or modify Janssen Link at any time

Getting Started With Janssen Link

Prescribe STELARA^®

Complete the Benefits Investigation and Prescription Form online in the Provider Portal or fax it to 866-769-3903

Complete Form Online Download Form